Tag: promise

CHAMPAIGN, Ill. – A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers. The drug stalled the growth of tumors in the five people in the trial with neuroendocrine cancers and reduced tumor size in two of those patients. It also showed some …

Vital Signs Monitoring Equipment Market Report Coverage: Key Growth Factors & Challenges, Segmentation & Regional Outlook, Top Industry Trends & Opportunities, Competition Analysis, COVID-19 Impact Analysis & Projected Recovery, and Market Sizing & Forecast. Latest launched research on Global Vital Signs Monitoring Equipment Market, it provides detailed analysis with presentable graphs, charts and tables. This report covers an in depth …

Credit: Unsplash / CC0 Public Domain There is tremendous potential in using regenerative medicine to relieve chronic pain, and the evidence for this practice is growing, said Alexios Carayannopoulos, DO, MPH, DABPMR, director of physical medicine and rehabilitation departments at Rhode Island Hospital and Newport Hospital, director of the Physical Medicine and Rehabilitation Department of the Lifespan Physician Group and …

Seelos therapeutics announced positive data in a rodent model of its CRISPR-dCAS9 gene therapy for Parkinson’s disease. This appears to be a second example of how CRISPR genes are manipulated in the body, as opposed to cell cultures. June 26th Intellia therapeutics and Regeneron Pharma announced Phase I human data from its in vivo gene editing candidate NTLA-2001 for transthyretin …